| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione binding | 4.58e-07 | 18 | 72 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 7.21e-07 | 20 | 72 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 3.45e-06 | 29 | 72 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 7.91e-05 | 122 | 72 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 8.38e-05 | 64 | 72 | 4 | GO:0016765 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.27e-04 | 5 | 72 | 2 | GO:0030156 | |
| GeneOntologyMolecularFunction | amide binding | 7.31e-04 | 299 | 72 | 6 | GO:0033218 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 1.56e-07 | 4 | 71 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.81e-06 | 37 | 71 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.00e-05 | 218 | 71 | 7 | GO:0006575 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 6.59e-05 | 63 | 71 | 4 | GO:0006749 | |
| GeneOntologyBiologicalProcess | cellular detoxification of nitrogen compound | 1.16e-04 | 5 | 71 | 2 | GO:0070458 | |
| GeneOntologyBiologicalProcess | detoxification of nitrogen compound | 1.16e-04 | 5 | 71 | 2 | GO:0051410 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 1.34e-04 | 29 | 71 | 3 | GO:0042759 | |
| Domain | GST_mu | 9.56e-10 | 5 | 71 | 4 | IPR003081 | |
| Domain | GST_N | 1.33e-06 | 22 | 71 | 4 | PF02798 | |
| Domain | GST_NTER | 1.33e-06 | 22 | 71 | 4 | PS50404 | |
| Domain | GST_C | 2.69e-06 | 26 | 71 | 4 | IPR004046 | |
| Domain | GST_C | 2.69e-06 | 26 | 71 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 3.15e-06 | 27 | 71 | 4 | IPR004045 | |
| Domain | GST_CTER | 8.16e-06 | 34 | 71 | 4 | PS50405 | |
| Domain | Glutathione-S-Trfase_C-like | 1.43e-05 | 39 | 71 | 4 | IPR010987 | |
| Domain | - | 1.43e-05 | 39 | 71 | 4 | 1.20.1050.10 | |
| Domain | BTB-kelch_protein | 5.83e-04 | 43 | 71 | 3 | IPR017096 | |
| Domain | GST_C_3 | 6.29e-04 | 10 | 71 | 2 | PF14497 | |
| Domain | Ubiquitin-rel_dom | 6.76e-04 | 184 | 71 | 5 | IPR029071 | |
| Domain | SSD | 1.08e-03 | 13 | 71 | 2 | IPR000731 | |
| Domain | SSD | 1.08e-03 | 13 | 71 | 2 | PS50156 | |
| Domain | - | 1.20e-03 | 122 | 71 | 4 | 3.40.30.10 | |
| Domain | Kelch | 1.40e-03 | 58 | 71 | 3 | SM00612 | |
| Domain | BACK | 1.54e-03 | 60 | 71 | 3 | SM00875 | |
| Domain | Thioredoxin-like_fold | 1.61e-03 | 132 | 71 | 4 | IPR012336 | |
| Domain | BACK | 1.62e-03 | 61 | 71 | 3 | PF07707 | |
| Domain | BACK | 1.62e-03 | 61 | 71 | 3 | IPR011705 | |
| Domain | LH2 | 2.10e-03 | 18 | 71 | 2 | SM00308 | |
| Domain | aa-tRNA-synth_II | 2.10e-03 | 18 | 71 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 2.10e-03 | 18 | 71 | 2 | PS50862 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | PF01344 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | IPR006652 | |
| Domain | PLAT | 2.86e-03 | 21 | 71 | 2 | PS50095 | |
| Domain | - | 2.86e-03 | 21 | 71 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.86e-03 | 21 | 71 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.86e-03 | 21 | 71 | 2 | IPR001024 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 6.12e-07 | 19 | 52 | 4 | M47809 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 1.38e-06 | 23 | 52 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 1.66e-06 | 24 | 52 | 4 | M47487 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 8.89e-06 | 36 | 52 | 4 | M1443 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.11e-05 | 38 | 52 | 4 | MM14600 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 3.34e-05 | 50 | 52 | 4 | M1840 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.26e-04 | 70 | 52 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.41e-04 | 72 | 52 | 4 | M9257 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 3.62e-04 | 92 | 52 | 4 | MM15823 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.42e-04 | 107 | 52 | 4 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 6.88e-04 | 109 | 52 | 4 | M18788 | |
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 19856098 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 18551009 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8471052 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8512323 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8473333 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 10587441 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 8373352 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 3.69e-08 | 4 | 74 | 3 | 8317488 | |
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 3.69e-08 | 4 | 74 | 3 | 19151192 | |
| Pubmed | 1.84e-07 | 6 | 74 | 3 | 1530570 | ||
| Pubmed | 1.96e-07 | 117 | 74 | 6 | 18977241 | ||
| Pubmed | 2.16e-07 | 119 | 74 | 6 | 17601350 | ||
| Pubmed | 4.96e-07 | 30 | 74 | 4 | 20200426 | ||
| Pubmed | 1.51e-06 | 11 | 74 | 3 | 15100242 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2689439 | ||
| Pubmed | Genomic organization and characterization of the promoter region of murine GSTM2 gene. | 4.47e-06 | 2 | 74 | 2 | 11404019 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3174634 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22924777 | ||
| Pubmed | Identification of a novel murine glutathione S-transferase class mu gene. | 4.47e-06 | 2 | 74 | 2 | 9480867 | |
| Pubmed | TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends. | 4.47e-06 | 2 | 74 | 2 | 32768523 | |
| Pubmed | Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer. | 4.47e-06 | 2 | 74 | 2 | 11173863 | |
| Pubmed | Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation. | 4.47e-06 | 2 | 74 | 2 | 27650951 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25977370 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8909248 | ||
| Pubmed | TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions. | 4.47e-06 | 2 | 74 | 2 | 27807101 | |
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 4.47e-06 | 2 | 74 | 2 | 22410570 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9545290 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24689813 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16399387 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 6822548 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18569590 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18692819 | ||
| Pubmed | Identification of a unique mu-class glutathione S-transferase in mouse spermatogenic cells. | 4.47e-06 | 2 | 74 | 2 | 8607970 | |
| Pubmed | GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration. | 4.47e-06 | 2 | 74 | 2 | 25897651 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8824514 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21513434 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 26553150 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16842493 | ||
| Pubmed | Purification and characterization of glutathione S-transferase of murine ovary and testis. | 1.34e-05 | 3 | 74 | 2 | 8442656 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 36013573 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18177825 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16328000 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 9230131 | ||
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 1.34e-05 | 3 | 74 | 2 | 32574561 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19486347 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 9452477 | ||
| Pubmed | GSTM1, GSTM3 and GSTT1 gene variants and risk of benign prostate hyperplasia in North India. | 1.34e-05 | 3 | 74 | 2 | 19407363 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 14968442 | ||
| Pubmed | Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines. | 1.34e-05 | 3 | 74 | 2 | 27466493 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18850183 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 12016153 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16549767 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16258256 | ||
| Pubmed | Glutathione S-transferase polymorphisms in osteosarcoma patients. | 1.34e-05 | 3 | 74 | 2 | 20577141 | |
| Pubmed | 2.16e-05 | 76 | 74 | 4 | 19336475 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 16886896 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 15459020 | ||
| Pubmed | [Potential genetic predictors for individual vulnerability to substance dependence]. | 2.67e-05 | 4 | 74 | 2 | 18411704 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 15115915 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 19922706 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11303592 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 14735473 | ||
| Pubmed | p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. | 2.67e-05 | 4 | 74 | 2 | 17292829 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11740339 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22406107 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 16509765 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11692073 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 16760134 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 17617661 | ||
| Pubmed | Polymorphisms in GSTM1, GSTT1, GSTP1, and GSTM3 genes and breast cancer risk in northeastern Mexico. | 2.67e-05 | 4 | 74 | 2 | 26125851 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 27021019 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11040079 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.67e-05 | 4 | 74 | 2 | 19091768 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 15338373 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 20391338 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 19889946 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 18390712 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11081456 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 17565746 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 17034008 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 12359356 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 15525789 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 25040976 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 4.45e-05 | 5 | 74 | 2 | 17855024 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 17083362 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 17353186 | ||
| Pubmed | [Glutathione-S-transferase gene polymorphism in Russian populations of European Russia]. | 4.45e-05 | 5 | 74 | 2 | 19062541 | |
| Pubmed | 5.76e-05 | 35 | 74 | 3 | 18992148 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 16112301 | ||
| Pubmed | N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. | 6.66e-05 | 6 | 74 | 2 | 11927838 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 20661821 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 19860743 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 17372252 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 19521675 | ||
| Pubmed | Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes. | 6.66e-05 | 6 | 74 | 2 | 20847076 | |
| Pubmed | 8.74e-05 | 493 | 74 | 7 | 15368895 | ||
| Pubmed | Mapping of the ARIX homeodomain gene to mouse chromosome 7 and human chromosome 11q13. | 9.31e-05 | 7 | 74 | 2 | 8661014 | |
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 17290392 | ||
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 8584275 | ||
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 12063626 | ||
| Interaction | GSTM5 interactions | 1.98e-07 | 15 | 72 | 4 | int:GSTM5 | |
| Interaction | GSTM2 interactions | 1.04e-06 | 22 | 72 | 4 | int:GSTM2 | |
| Interaction | GSTM1 interactions | 1.93e-05 | 15 | 72 | 3 | int:GSTM1 | |
| Interaction | GSTM4 interactions | 2.37e-05 | 16 | 72 | 3 | int:GSTM4 | |
| Cytoband | 1p13.3 | 9.83e-08 | 69 | 74 | 5 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 2.43e-05 | 211 | 74 | 5 | chr1p13 | |
| Cytoband | 15q15.1 | 6.19e-05 | 47 | 74 | 3 | 15q15.1 | |
| GeneFamily | Glutathione S-transferases | 7.36e-07 | 25 | 52 | 4 | 567 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 176 | 74 | 6 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 176 | 74 | 6 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 176 | 74 | 5 | 56e19240f4a7b617a986e3c0854b757394e78251 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 176 | 74 | 5 | c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 180 | 74 | 5 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 180 | 74 | 5 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.32e-05 | 182 | 74 | 5 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 184 | 74 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-05 | 187 | 74 | 5 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | 44631226f59364098a7dd58058e6970a75441009 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | f892f725a32e704cd18fec2f6d1db82993e7e79a | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | 34b54bea013c8c724fadae357e29953c291bfce1 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | 9a5dd7ae6de72a000cf9a0d42f6b0884fa43f345 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 199 | 74 | 5 | a538da095ba996ee96e263442cf5b6ba9178f3d4 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.02e-05 | 199 | 74 | 5 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 200 | 74 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-05 | 200 | 74 | 5 | 28e5354008adf97b17333f17f8cbef930db6729a | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 74 | 5 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 200 | 74 | 5 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.07e-05 | 200 | 74 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 200 | 74 | 5 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.07e-05 | 200 | 74 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 74 | 5 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 200 | 74 | 5 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 74 | 5 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-05 | 200 | 74 | 5 | 56536236a7012efdb28f85b40e464f3da3e87ce8 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-04 | 148 | 74 | 4 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 149 | 74 | 4 | 4034805c4eefb8bfb3a357273ccbdb77283ea4a5 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 149 | 74 | 4 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 152 | 74 | 4 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 157 | 74 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 162 | 74 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-04 | 165 | 74 | 4 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-04 | 166 | 74 | 4 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 168 | 74 | 4 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 168 | 74 | 4 | b4bb03efb601a61465260f93896c56861c588bef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 168 | 74 | 4 | 240ea32b64d86f9216785010d6b237d9adf052c9 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 169 | 74 | 4 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 169 | 74 | 4 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 174 | 74 | 4 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 176 | 74 | 4 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 176 | 74 | 4 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.24e-04 | 179 | 74 | 4 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-04 | 179 | 74 | 4 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 179 | 74 | 4 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 179 | 74 | 4 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 179 | 74 | 4 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 179 | 74 | 4 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 180 | 74 | 4 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-04 | 181 | 74 | 4 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-04 | 183 | 74 | 4 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 183 | 74 | 4 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-04 | 183 | 74 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 74 | 4 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 74 | 4 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 74 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-04 | 188 | 74 | 4 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 189 | 74 | 4 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-04 | 189 | 74 | 4 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 189 | 74 | 4 | 7c6d586f352d0d44c24079e76272cb3a545441b5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.76e-04 | 189 | 74 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 189 | 74 | 4 | 5438baaa3056fec46d59f75f03f27a93601936c1 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 2.81e-04 | 190 | 74 | 4 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | 7be1164220adaaf7f77995868e5ed45343e6f662 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | 68ba5b762b6c4198ffd3d576a240303cc24954cb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.87e-04 | 191 | 74 | 4 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.87e-04 | 191 | 74 | 4 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.87e-04 | 191 | 74 | 4 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.87e-04 | 191 | 74 | 4 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.87e-04 | 191 | 74 | 4 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 1f660ea2841324d13f63e01f1789e606c2843fc4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.87e-04 | 191 | 74 | 4 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.93e-04 | 192 | 74 | 4 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.93e-04 | 192 | 74 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 0ca0439dfdcb2361ca8d1015fb874a5b5c635d31 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.99e-04 | 193 | 74 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 124364adb3ded77282d449dd2cb039e6f2403a39 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | d08919db9601941569b9a143dad4d8e6f56a4389 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 194 | 74 | 4 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-04 | 194 | 74 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| Computational | ROS metabolism. | 6.61e-07 | 22 | 35 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 4.56e-04 | 10 | 35 | 2 | MODULE_101 | |
| Drug | tiadenol | 2.37e-08 | 57 | 71 | 6 | CID000023403 | |
| Drug | piriprost | 3.25e-08 | 60 | 71 | 6 | CID006437373 | |
| Drug | halothane | 4.74e-08 | 314 | 71 | 10 | CID000003562 | |
| Drug | C14791 | 2.57e-07 | 18 | 71 | 4 | CID011954044 | |
| Drug | C14793 | 2.57e-07 | 18 | 71 | 4 | CID011954046 | |
| Drug | C14803 | 2.57e-07 | 18 | 71 | 4 | CID011954054 | |
| Drug | C14805 | 2.57e-07 | 18 | 71 | 4 | CID011954056 | |
| Drug | C14804 | 2.57e-07 | 18 | 71 | 4 | CID011954055 | |
| Drug | C14806 | 2.57e-07 | 18 | 71 | 4 | CID011954057 | |
| Drug | C14848 | 2.57e-07 | 18 | 71 | 4 | CID011954067 | |
| Drug | C14856 | 2.57e-07 | 18 | 71 | 4 | CID011954069 | |
| Drug | C14855 | 2.57e-07 | 18 | 71 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 2.57e-07 | 18 | 71 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 2.57e-07 | 18 | 71 | 4 | CID000188517 | |
| Drug | Clch2cosg | 2.57e-07 | 18 | 71 | 4 | CID000163913 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 4.05e-07 | 20 | 71 | 4 | CID011954072 | |
| Drug | C14865 | 4.05e-07 | 20 | 71 | 4 | CID011954073 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 5.77e-07 | 6 | 71 | 3 | ctd:C042630 | |
| Drug | chloroacetyl chloride | 7.88e-07 | 55 | 71 | 5 | CID000006577 | |
| Drug | S-(formylmethyl)glutathione | 8.80e-07 | 24 | 71 | 4 | CID011954074 | |
| Drug | perhexiline | 1.03e-06 | 58 | 71 | 5 | CID000004746 | |
| Drug | AC1L1AL2 | 1.60e-06 | 115 | 71 | 6 | CID000001035 | |
| Drug | AC1Q608X | 1.68e-06 | 28 | 71 | 4 | CID000128466 | |
| Drug | AC1L33DC | 1.68e-06 | 28 | 71 | 4 | CID000133757 | |
| Drug | 2-BHA | 1.94e-06 | 29 | 71 | 4 | CID000006932 | |
| Drug | AC1NSK22 | 1.97e-06 | 66 | 71 | 5 | CID005311131 | |
| Drug | AC1L1Z2L | 2.36e-06 | 123 | 71 | 6 | CID000012201 | |
| Drug | o-dinitrobenzene | 2.56e-06 | 31 | 71 | 4 | CID000010707 | |
| Drug | Dcvg | 2.56e-06 | 31 | 71 | 4 | CID006437359 | |
| Drug | stilbene oxide | 3.48e-06 | 74 | 71 | 5 | CID000028649 | |
| Drug | prostaglandin I3 | 3.75e-06 | 34 | 71 | 4 | CID005283049 | |
| Drug | m-toluidine | 3.75e-06 | 34 | 71 | 4 | CID000007934 | |
| Drug | Lyndiol | 3.75e-06 | 34 | 71 | 4 | CID000082149 | |
| Drug | dimethoxystrychnine | 4.22e-06 | 35 | 71 | 4 | CID000009649 | |
| Drug | Dixan | 4.22e-06 | 35 | 71 | 4 | CID000010404 | |
| Drug | oltipraz | 4.42e-06 | 137 | 71 | 6 | CID000047318 | |
| Drug | Glutathione | 4.74e-06 | 36 | 71 | 4 | DB00143 | |
| Drug | anti-OX | 4.82e-06 | 79 | 71 | 5 | CID000008398 | |
| Drug | Dietary Fats, Unsaturated | 4.82e-06 | 79 | 71 | 5 | ctd:D004042 | |
| Drug | clofibrate | 5.58e-06 | 311 | 71 | 8 | CID000002796 | |
| Drug | clotrimazole | 5.66e-06 | 143 | 71 | 6 | CID000002812 | |
| Drug | Ethoxyquin | 7.29e-06 | 40 | 71 | 4 | ctd:D005015 | |
| Drug | ethanol | GSTM1 GSTM3 GSTM4 GPI GSTM5 IL11 CLSTN2 PLCH1 TERT ADCY1 ENPEP GLP2R | 9.81e-06 | 837 | 71 | 12 | CID000000702 |
| Drug | 4-hydroxyanisole | 1.28e-05 | 46 | 71 | 4 | CID000009015 | |
| Drug | C14802 | 1.40e-05 | 47 | 71 | 4 | CID011954053 | |
| Drug | C14800 | 1.52e-05 | 48 | 71 | 4 | CID011954051 | |
| Drug | EUK-189 | 1.58e-05 | 16 | 71 | 3 | ctd:C436526 | |
| Drug | chlorpyrifos | 1.60e-05 | 101 | 71 | 5 | CID000002730 | |
| Drug | bromobenzene-3,4-oxide | 1.65e-05 | 49 | 71 | 4 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 1.79e-05 | 50 | 71 | 4 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 1.79e-05 | 50 | 71 | 4 | CID000119521 | |
| Drug | phenanthroline | 1.79e-05 | 50 | 71 | 4 | CID000067473 | |
| Drug | naphthalene epoxide | 1.94e-05 | 51 | 71 | 4 | CID000108063 | |
| Drug | hypericin | 2.22e-05 | 108 | 71 | 5 | CID005281051 | |
| Drug | CAS 81-11-8 | 2.43e-05 | 110 | 71 | 5 | CID000006668 | |
| Drug | dichloroacetaldehyde | 2.44e-05 | 54 | 71 | 4 | CID000006576 | |
| Drug | S-hexylglutathione | 2.63e-05 | 55 | 71 | 4 | CID000005140 | |
| Drug | 2-(4-toluidino)-6-naphthalenesulfonic acid | 2.87e-05 | 3 | 71 | 2 | ctd:C009497 | |
| Drug | daunorubicin semiquinone | 3.00e-05 | 285 | 71 | 7 | CID000002958 | |
| Drug | cyclohexanone | 3.03e-05 | 57 | 71 | 4 | CID000007967 | |
| Drug | ethoxyquin | 3.13e-05 | 116 | 71 | 5 | CID000003293 | |
| Drug | bromoacetaldehyde | 3.24e-05 | 58 | 71 | 4 | CID000105131 | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 7360_DN | |
| Drug | 2-butyl-6-methoxyphenol | 3.49e-05 | 197 | 71 | 6 | CID011954184 | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 6738_DN | |
| Drug | dibenzoylmethane | 3.71e-05 | 21 | 71 | 3 | ctd:C061481 | |
| Drug | PenCB | 3.96e-05 | 61 | 71 | 4 | CID000036188 | |
| Drug | NSC39143 | 3.96e-05 | 61 | 71 | 4 | CID000002579 | |
| Drug | BP-4,5-oxide | 3.96e-05 | 61 | 71 | 4 | CID000037786 | |
| Drug | zinc sulfate | 6.44e-05 | 69 | 71 | 4 | CID000024424 | |
| Drug | ethacrynic acid | 7.18e-05 | 138 | 71 | 5 | CID000003278 | |
| Drug | benzyl isothiocyanate | 7.20e-05 | 71 | 71 | 4 | CID000002346 | |
| Drug | 1,2-dibromoethane | 7.20e-05 | 71 | 71 | 4 | CID000007839 | |
| Drug | NSC9567 | 7.95e-05 | 141 | 71 | 5 | CID000003001 | |
| Drug | CAS 87-33-2 | 8.03e-05 | 73 | 71 | 4 | CID000003780 | |
| Drug | 2,4,6-trinitrotoluene | 8.93e-05 | 75 | 71 | 4 | CID000008376 | |
| Drug | CoCl2 | 8.93e-05 | 75 | 71 | 4 | CID003015678 | |
| Drug | cobalt(II) chloride | 9.38e-05 | 146 | 71 | 5 | CID000024288 | |
| Drug | 2-hexadecynoic acid | 9.53e-05 | 5 | 71 | 2 | CID000151047 | |
| Drug | 2-dB | 9.53e-05 | 5 | 71 | 2 | CID011957419 | |
| Drug | AC1O5MYK | 9.89e-05 | 77 | 71 | 4 | CID006437077 | |
| Drug | BP-7,8-diol | 1.04e-04 | 78 | 71 | 4 | CID000025892 | |
| Drug | Prostaglandin D2-d4 | 1.04e-04 | 240 | 71 | 6 | CID000004956 | |
| Drug | 8-iso-prostaglandin E2 | 1.04e-04 | 603 | 71 | 9 | CID000000158 | |
| Drug | AC1N2DGT | 1.11e-04 | 30 | 71 | 3 | CID004045015 | |
| Drug | PCB 126 | 1.15e-04 | 80 | 71 | 4 | CID000063090 | |
| Drug | indole-3-carbinol | 1.21e-04 | 154 | 71 | 5 | CID000003712 | |
| Drug | phenobarbital | 1.30e-04 | 360 | 71 | 7 | CID000004763 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 1.43e-04 | 6 | 71 | 2 | ctd:C028328 | |
| Drug | trichloroethylene | 1.66e-04 | 88 | 71 | 4 | CID000006575 | |
| Drug | aminotriazole | 1.76e-04 | 167 | 71 | 5 | CID000001639 | |
| Drug | bromide | 1.86e-04 | 267 | 71 | 6 | CID000000259 | |
| Drug | N-ethylmaleimide | 1.88e-04 | 511 | 71 | 8 | CID000004362 | |
| Drug | Gsts | 2.08e-04 | 173 | 71 | 5 | CID000128079 | |
| Drug | PCB 77 | 2.51e-04 | 98 | 71 | 4 | CID000036187 | |
| Drug | glutathione reduced | 2.53e-04 | 534 | 71 | 8 | CID000000745 | |
| Drug | dimaprit | 2.64e-04 | 40 | 71 | 3 | CID000003077 | |
| Drug | triethyllead | 2.65e-04 | 8 | 71 | 2 | ctd:C010360 | |
| Drug | SRI 63-675 | 2.65e-04 | 8 | 71 | 2 | CID000122013 | |
| Drug | kahweol palmitate | 2.65e-04 | 8 | 71 | 2 | ctd:C033997 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 1.45e-10 | 5 | 70 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | colorectal adenoma (is_implicated_in) | 5.52e-05 | 5 | 70 | 2 | DOID:0050860 (is_implicated_in) | |
| Disease | larynx cancer (is_implicated_in) | 8.27e-05 | 6 | 70 | 2 | DOID:2596 (is_implicated_in) | |
| Disease | Degenerative Diseases, Central Nervous System | 1.10e-04 | 39 | 70 | 3 | C0270715 | |
| Disease | Neurodegenerative Disorders | 1.10e-04 | 39 | 70 | 3 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 1.10e-04 | 39 | 70 | 3 | C0751733 | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0022012 | |
| Disease | phospholipids in medium HDL measurement | 3.07e-04 | 55 | 70 | 3 | EFO_0022295 | |
| Disease | total lipids in medium HDL measurement | 3.59e-04 | 58 | 70 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.59e-04 | 58 | 70 | 3 | EFO_0022267 | |
| Disease | Malignant neoplasm of liver | 3.68e-04 | 142 | 70 | 4 | C0345904 | |
| Disease | Liver neoplasms | 3.68e-04 | 142 | 70 | 4 | C0023903 | |
| Disease | phospholipids in HDL measurement | 4.17e-04 | 61 | 70 | 3 | EFO_0022293 | |
| Disease | semaphorin-3A measurement | 5.71e-04 | 15 | 70 | 2 | EFO_0008278 | |
| Disease | neutrophil collagenase measurement | 6.52e-04 | 16 | 70 | 2 | EFO_0008248 | |
| Disease | Corneal astigmatism | 8.25e-04 | 77 | 70 | 3 | EFO_1002040 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 8.83e-04 | 312 | 70 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 9.22e-04 | 315 | 70 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.00e-03 | 321 | 70 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | saturated fatty acids to total fatty acids percentage | 1.13e-03 | 21 | 70 | 2 | EFO_0022305 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.13e-03 | 330 | 70 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | vitronectin measurement | 1.36e-03 | 23 | 70 | 2 | EFO_0021843 | |
| Disease | obesity (implicated_via_orthology) | 1.73e-03 | 215 | 70 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | macular degeneration (is_marker_for) | 1.74e-03 | 26 | 70 | 2 | DOID:4448 (is_marker_for) | |
| Disease | cystic fibrosis (is_implicated_in) | 1.87e-03 | 27 | 70 | 2 | DOID:1485 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 2.02e-03 | 28 | 70 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | phospholipids:total lipids ratio | 2.10e-03 | 227 | 70 | 4 | EFO_0020946 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 2.31e-03 | 30 | 70 | 2 | DOID:332 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WCGYLHRRDLERILL | 716 | Q8N163 | |
| DLARLRGVHYITWRR | 456 | Q5NDL2 | |
| AHWRIELIFLARGDA | 271 | Q9P2K9 | |
| PHYLLERRDLWRREA | 246 | Q9H0I2 | |
| WRLFREILDGLAYIH | 826 | Q9P2K8 | |
| RGYHIRDWELRKIHR | 26 | A2A2Z9 | |
| ELAILDRLHWDLYIG | 236 | Q6ZMN8 | |
| RHSLWDILLKYREGR | 4011 | Q86UQ4 | |
| FRYLQRLLLVHGRWS | 851 | Q8TF62 | |
| HIRYRNWRPASLEAR | 751 | Q9H4D0 | |
| REYVHARLLRAGLSW | 36 | Q9UMX3 | |
| WLPASAVLHERYLAR | 636 | A7MBM2 | |
| HAYRLLRVLSSWRED | 66 | Q5W186 | |
| LREVSLVWHLYGGRD | 1421 | Q2TAZ0 | |
| RGYHIRDWELRKIHR | 26 | Q9H560 | |
| WEYLARLRSHRKSIR | 731 | Q8TBY9 | |
| HYRVRVEVRLPWDLL | 1051 | A6NNM3 | |
| HYRVRVEVRLPWDLL | 1051 | A6NJZ7 | |
| LYVRHFLWGLRSRAS | 801 | Q96JH8 | |
| GLERLWSKARHYLLT | 86 | A6NCF5 | |
| LHDLREIEAWIYRLL | 241 | Q8WXG6 | |
| DIGRKLWIYLHRDRS | 641 | Q6P4R8 | |
| RIIHRLLRIHFDGWE | 516 | Q05BQ5 | |
| GYWDIRGLAHAIRLL | 6 | P46439 | |
| YRDLLRTSRVHWIAE | 301 | O75648 | |
| LRWLPVLRHYDLDLV | 46 | Q02083 | |
| RGEILWSHLELLRKY | 236 | Q06546 | |
| LLSYLRHVQWLRRAG | 101 | P20809 | |
| LLSRYEDTWAALHRR | 51 | Q96EV8 | |
| HISERVLWDLGRDFR | 566 | Q8IY47 | |
| GHSAKRYLRGLLRTW | 151 | Q0VF49 | |
| WYREHRSELNLRRLF | 16 | P06744 | |
| YWDIRGLAHAIRLLL | 11 | P21266 | |
| RSYPHLEGDVRWRRL | 31 | Q9HCT0 | |
| YLWLHLRETRITRLP | 131 | Q07075 | |
| AHDALRLWEIIARYV | 461 | P18054 | |
| RLWEIIARYVEGIVH | 466 | P18054 | |
| RVRLSWATHYVGDLR | 246 | Q8IWF2 | |
| LWQHRVESRLLRDYA | 631 | Q8IWF2 | |
| EVLRRHRTYRWLSAE | 351 | Q16795 | |
| IYLSGLRSWKRHLSR | 31 | Q8TCG5 | |
| HARQVDIRLRLDYLW | 801 | Q08828 | |
| ELRKYWVRFLLARHS | 446 | O95838 | |
| WVYRAVDLRRPLLHE | 236 | Q6TFL4 | |
| RAYIDRLLHLWGRET | 331 | Q5SW24 | |
| AVGGLLFYRWRRRSH | 511 | P09603 | |
| TRGRLHHWLYRLQEA | 151 | Q8IZJ0 | |
| DYGRRLSADIRLRSW | 741 | O60307 | |
| EEYVDRRLHRLWGSL | 301 | Q9NT22 | |
| RRLHRLWGSLLDGFE | 306 | Q9NT22 | |
| FLERLHLFLAREGWT | 101 | Q8ND90 | |
| RQLRRLRELHLYSTW | 91 | P0C7A2 | |
| LGAVILRWRYHALRG | 4101 | P98161 | |
| HVRYWVKDRSLRLHR | 296 | P59541 | |
| VTWRRRQHLLAYLRE | 211 | Q9BSD3 | |
| LAHYRRWGDSVLLVD | 206 | Q9BYD3 | |
| LSRPASWDRIRHYRI | 136 | Q9H6Q3 | |
| ERFLTWILNRYHIRD | 521 | O43776 | |
| LWGLHRLYGCLDRLF | 246 | O75900 | |
| LARRAHRSKWLESYL | 246 | Q16647 | |
| VLRLYKRALRHLESW | 16 | Q9Y6M9 | |
| GYWDIRGLAHAIRLL | 6 | Q03013 | |
| HRGWLARRLSYVLFI | 101 | Q9HCL2 | |
| GYWDIRGLAHAIRLL | 6 | P09488 | |
| LWREVTRYLRLGDID | 701 | Q9BXB5 | |
| RGHRTYARRWVFLLA | 21 | Q6UXD7 | |
| HGFLVWRYLLRRDDV | 601 | Q96PU4 | |
| VLYWCRRTDPALLRH | 211 | Q6SZW1 | |
| RALVGRELFWHALRE | 226 | Q96JH7 | |
| LFYLDEHRTRLRWRP | 41 | Q4KWH8 | |
| SLVSRHRGALFRWLE | 71 | O43149 | |
| HRGALFRWLEERLGR | 76 | O43149 | |
| GTLRLWEYRSGRQLH | 211 | P57081 | |
| RWYTAHRTLTIELRR | 351 | Q9NVH6 | |
| DRVLCLHSRWRILYA | 1616 | Q9H2Y7 | |
| LGLDDIHRAWRTFVL | 681 | O14746 | |
| WDVTYLLRGLLGRHA | 41 | Q96DZ7 | |
| IARRLHQRLRAEYLW | 851 | Q13402 |